- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02024256
Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery (MgSo4)
Comparison Between Treatment With Gauze Soaked With Cold Magnesium Sulfate Solution Against Gauze Soaked With Cold Water for Treatment of Perineal Swelling Following Vaginal Delivery - A Double Blind Placebo Controlled Trial
The purpose of this study is to compare the impact of treatment with cooled magnesium sulfate and cold water-soaked pads on perineal pain and swelling following vaginal delivery.
Assessment of appropriateness for each patient to take part in the study will be performed approximately 2 hours following delivery. Those patients who consent to participate in the trial will be allocated to treatment groups in a double-blinded, randomized manner. Women in the study group will receive treatment with pads soaked in a cold aqueous solution of magnesium sulfate at 33% (w/v) concentration, while those in the control group will receive treatment with pads soaked in cold water.
Nurses will initiate treatment according to the group to which the patient was randomized. Said pads will be given the patients routinely 5 times a day at regular times.
A physician will assess the perineal swelling according to visual (photographed) scale in which severe, moderate, light and no swelling will be defined. Measurement of swelling in centimeters (maximal length and breadth); photography, by a medical photographer or the examining doctor, of the perineal area with a centimeter ruler, before, during and after treatment (photography is dependent on patient approval and is not a precondition to participation in the trial.); and additional examination, on the above basis, will be performed regarding hemorrhoids in the event that a patient has complained of such.
A nurse will assess the perineal pain and swelling on a scale ranging from 0 to 10 prior to the patient being given the pad and an hour following treatment. An additional assessment by the same method will be performed regarding hemorrhoid pain. Any analgesia administered will also be recorded.
Likewise, for follow-up purposes a blood test for serum magnesium concentration will be taken before and after treatment.
Period of follow-up will be 48-72 hours from childbirth.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Afula, Israel
- Recruiting
- HaEmek Medical Center
-
Principal Investigator:
- Nahum Zohar, MD
-
Afula, Israel, 18101
- Recruiting
- HeEmek medical center
-
Contact:
- Zohar Nahum, md
- Phone Number: 97241584649
- Email: nachum_zo@clalit.org.il
-
Contact:
- Irit Friedman
- Phone Number: 972546202261
- Email: iritdavid@gmail.com, irit_da@clalit.org.il
-
Principal Investigator:
- Zohar Nahum, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- parturients following normal vaginal birth or vacuum-assisted vaginal delivery
- reporting of perineal pain equal to or greater than 3 on a 0-10 scale
Exclusion Criteria:
- parturients following cesarean section
- lack of consent to take part in the study
- parturients interested in early discharge (within 48 hours of childbirth)
- girls under 18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Magnesium sulfate
Pads soaked in cold magnesium sulfate solution
|
Other Names:
|
|
Sham Comparator: Water
Pads soaked with cold water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Reduction in the level of perineal pain
Time Frame: 3 days
|
3 days
|
|
Reduction in perineal swelling
Time Frame: 3 days
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Reduction in hemorrhoids pain and swelling
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zohar Nahum, MD, HaEmek medical center affiliated to Rappaport faculty of medicine, Technion, Haifa, Israel
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anticonvulsants
- Calcium-Regulating Hormones and Agents
- Reproductive Control Agents
- Calcium Channel Blockers
- Tocolytic Agents
- Magnesium Sulfate
Other Study ID Numbers
- MG33
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Delivery
-
Cairo UniversityCompleted
-
Ain Shams Maternity HospitalRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Cairo UniversityUnknownVaginal DeliveryEgypt
-
Faculty Hospital Kralovske VinohradyCompletedPotential of Vojta's Reflex Locomotion as a Pre/Induction Method for Uterine Activity: a Pilot StudyInduced Vaginal DeliveryCzechia
-
Sohag UniversityNot yet recruitingVaginal Delivery
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruiting
-
Cairo UniversityCompletedVaginal DeliveryEgypt
Clinical Trials on Cold pads soaked in Magnesium sulfate solution
-
Southern California College of Optometry at Marshall...Alcon ResearchCompletedContact Lens Disinfecting SolutionsUnited States
-
Tata Main HospitalRecruiting
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPostoperative Pain | Back Pain Lower Back ChronicTurkey (Türkiye)
-
Cairo UniversitySuez Canal UniversityRecruitingCerebral Palsy | Magnesium Sulfate OverdoseEgypt
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedPostoperative Pain | Spinal Anesthesia | Dexmedetomidine | Magnesium Sulfate | Bladder Tumors | Hemodynamic and Respiratory MonitoringTurkey (Türkiye)
-
Ankara City Hospital BilkentCompletedHypertension | TachycardiaTurkey (Türkiye)
-
Zagazig UniversityNot yet recruitingHemodynamic Instability | Infertility FemaleEgypt
-
The Baruch Padeh Medical Center, PoriyaRecruitingWomen After Delivery With Perineal PainIsrael
-
Quanta MedicalCousin BiotechCompleted
-
Loma Linda UniversityRecruitingMagnesium Sulfate | Intraoperative Neurophysiological MonitoringUnited States